RAMM Pharma Corp. (CSE:RAMM)

RAMM Pharma Revenue

RAMM Pharma had revenue of 1.01M CAD in the quarter ending January 31, 2025, with 5.75% growth. This brings the company's revenue in the last twelve months to 4.40M, down -6.32% year-over-year. In the fiscal year ending October 31, 2024, RAMM Pharma had annual revenue of 4.34M, down -14.28%.

• Revenue (ttm): 4.40M
• Revenue Growth: -6.32%
• P/S Ratio: 0.41
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	4.34M	-723.29K	-14.28%
Oct 31, 2023	5.07M	1.17M	29.96%
Oct 31, 2022	3.90M	-218.63K	-5.31%
Oct 31, 2021	4.12M	-1.33M	-24.40%
Oct 31, 2020	5.44M	-165.89K	-2.96%